| scholarly article | Q13442814 |
| P50 | author | Gerd Sutter | Q38804711 |
| Simone Hornemann | Q57587562 | ||
| Caroline Staib | Q104038188 | ||
| Volker Erfle | Q104038370 | ||
| P2093 | author name string | Bernd Kaspers | |
| Georg Häcker | |||
| Sigrid Kisling | |||
| Olof Harlin | |||
| P2860 | cites work | The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase | Q24561643 |
| The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms | Q24642586 | ||
| Caspases: enemies within | Q29547315 | ||
| A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry | Q29617253 | ||
| Cell death: the significance of apoptosis | Q29617620 | ||
| Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain | Q33781751 | ||
| Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. | Q33803714 | ||
| Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model | Q33835582 | ||
| Immunology 101 at poxvirus U: immune evasion genes | Q34209968 | ||
| Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. | Q34337534 | ||
| The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses | Q34469355 | ||
| The interaction of orthopoxviruses and interferon-treated cultured cells | Q34806012 | ||
| Convenient assay for interferons | Q35235975 | ||
| Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. | Q35830193 | ||
| Delay of vaccinia virus-induced apoptosis in nonpermissive Chinese hamster ovary cells by the cowpox virus CHOhr and adenovirus E1B 19K genes. | Q35830976 | ||
| Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. | Q35849390 | ||
| Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. | Q35861490 | ||
| Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits | Q35863825 | ||
| Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. | Q35878092 | ||
| Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model | Q35946213 | ||
| Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant. | Q36621273 | ||
| Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene | Q36765625 | ||
| Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates | Q36924415 | ||
| Relative sensitivities of viruses to different species of interferon | Q37135472 | ||
| Nonreplicating vaccinia vector efficiently expresses recombinant genes | Q37299518 | ||
| The genome of fowlpox virus | Q39590582 | ||
| Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector | Q39592790 | ||
| Cloning and expression of foreign genes in vaccinia virus, using a host range selection system | Q40116789 | ||
| A cowpox virus gene required for multiplication in Chinese hamster ovary cells. | Q40127465 | ||
| The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range | Q40712234 | ||
| MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl) | Q40901244 | ||
| Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo | Q40923272 | ||
| Overexpression of chicken interferon regulatory factor-1 (Ch-IRF-1) induces constitutive expression of MHC class I antigens but does not confer virus resistance to a permanent chicken fibroblast cell line | Q40992128 | ||
| Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine | Q41039759 | ||
| Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. | Q41047354 | ||
| Apoptosis induced by a postbinding step of vaccinia virus entry into Chinese hamster ovary cells | Q41059681 | ||
| Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells | Q41064284 | ||
| Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line | Q41076591 | ||
| Host-range restriction of vaccinia virus E3L-specific deletion mutants | Q41246413 | ||
| Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses | Q41326428 | ||
| Interferon induction in peripheral blood mononuclear leukocytes of man and farm animals by poxvirus vector candidates and some poxvirus constructs | Q41343086 | ||
| Recombinant chicken interferon: a potent antiviral agent that lacks intrinsic macrophage activating factor activity | Q41367222 | ||
| Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis | Q41372393 | ||
| Caspases: intracellular signaling by proteolysis | Q41656258 | ||
| Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence | Q41684943 | ||
| Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis | Q42156172 | ||
| Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon α Transmembrane Signaling | Q42679205 | ||
| Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity | Q43786335 | ||
| Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. | Q44022556 | ||
| Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara | Q44138669 | ||
| The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation | Q44206768 | ||
| Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus | Q45099279 | ||
| Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. | Q45737034 | ||
| Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model | Q45737949 | ||
| Transient host range selection for genetic engineering of modified vaccinia virus Ankara | Q45741853 | ||
| Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA. | Q45746795 | ||
| The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys | Q45754566 | ||
| Complementation of deletion of the vaccinia virus E3L gene by the Escherichia coli RNase III gene | Q45765133 | ||
| Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model | Q45765329 | ||
| Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. | Q45779943 | ||
| A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus | Q45782130 | ||
| Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity | Q45785576 | ||
| Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system | Q45796736 | ||
| Inhibition of early vaccinia virus protein synthesis in interferon-treated chicken embryo fibroblasts | Q45815125 | ||
| Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon | Q45859752 | ||
| Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro | Q67675801 | ||
| Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity | Q70178030 | ||
| The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis | Q71613218 | ||
| Studies on poxvirus infections in irradiated animals | Q72861146 | ||
| Dominant host range selection of vaccinia recombinants by rescue of an essential gene | Q77310741 | ||
| Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS | Q77323993 | ||
| Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells | Q77729442 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Vaccinia virus | Q1986297 |
| P304 | page(s) | 8394-8407 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L. | |
| P478 | volume | 77 |
| Q54631516 | A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. |
| Q35023806 | A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells |
| Q82014730 | A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus |
| Q34651266 | Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene |
| Q30426730 | Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice |
| Q35656345 | Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity |
| Q37309247 | Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors |
| Q35914427 | Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors |
| Q35947683 | Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC. |
| Q47233214 | E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox |
| Q52690434 | Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox. |
| Q33635050 | Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice |
| Q39680805 | Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells |
| Q28659589 | Generation of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genes |
| Q36559594 | HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation |
| Q40281364 | Induction of apoptosis limits cytomegalovirus cross-species infection |
| Q40930897 | Interferon induction by avian reovirus |
| Q28223836 | Modified Vaccinia Virus Ankara |
| Q35961192 | Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential? |
| Q45437312 | Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis |
| Q37201850 | Poxvirus host range genes |
| Q28237434 | Poxvirus tropism |
| Q34262138 | Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara |
| Q38096489 | Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets |
| Q38331191 | Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes |
| Q35800430 | Selection of recombinant MVA by rescue of the essential D4R gene |
| Q39441885 | The cellular antiviral restriction factor tetherin does not inhibit poxviral replication |
| Q37204575 | The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells. |
| Q38112854 | Utilizing poxviral vectored vaccines for antibody induction-progress and prospects |
| Q38304602 | Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells. |
| Q36949602 | Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3. |
| Q42093151 | Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components |
| Q36750723 | Viral suppression of the interferon system |
| Q42984516 | Viral vaccine meeting held in Barcelona, October 25-28, 2003. |
| Q37646066 | Viruses as vaccine vectors for infectious diseases and cancer |
Search more.